Should Stereotactic Ablative Radiotherapy Be Used for Oligometastatic Disease?

Robert A Olson1, David A Palma2

  • 1The University of British Columbia, Vancouver, BC, Canada.

NEJM Evidence
|February 6, 2024
PubMed